Roland Gustavson is a strategic and impactful leader with over 25 years of experience in Market Access, Reimbursement, Sales Leadership, and Commercial Training & Development, particularly within the oncology sector. Currently serving as the National Senior Manager of Oncology Field Reimbursement at AbbVie, Roland is...
Roland Gustavson is a strategic and impactful leader with over 25 years of experience in Market Access, Reimbursement, Sales Leadership, and Commercial Training & Development, particularly within the oncology sector. Currently serving as the National Senior Manager of Oncology Field Reimbursement at AbbVie, Roland is at the forefront of launching national reimbursement and access initiatives in the hematology space. His role is pivotal as he spearheads AbbVie’s inaugural oncology field access initiative, focusing on the oral drug Imbruvica and the injectable Epkinly.
Under his leadership, the National Oncology Field Reimbursement Team is dedicated to navigating the complexities of reimbursement processes and ensuring that both major academic and community oncology accounts have the support they need to access these critical therapies. Roland's expertise in account management and project management is instrumental in fostering strong relationships with key stakeholders, including industry alliance partners such as Pharmacyclics, JBI, and Genmab. His senior-level decision-making skills enable him to effectively align strategies across these partnerships, ensuring that AbbVie remains a leader in oncology access solutions.
With a robust background in market access and product launch, Roland is adept at driving business development initiatives that enhance patient access to innovative therapies. His proficiency in the Buy & Bill model and comprehensive understanding of pain management further position him as a valuable asset in the oncology landscape. As he continues to lead his team through the evolving challenges of the healthcare environment, Roland remains committed to improving patient outcomes and advancing the field of oncology through strategic access initiatives.
